Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 4 Date: 19 Sep 2024
Reviewer's report:
Review of the manuscript:
Risk of clostridium difficile infection in inflammatory bowel Disease patients undergoing
vedolizumab treatment: a systematic review and meta-analysis
Thank you again for the kind invitation.
After the revision of the manuscript by  the authors and as I already mentioned in our previous
contact, I believe that the manuscript may be published in the recently submitted form.
Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 4 Date: 19 Sep 2024
Reviewer's report:
Review of the manuscript:
Risk of clostridium difficile infection in inflammatory bowel Disease patients undergoing
vedolizumab treatment: a systematic review and meta-analysis
Thank you again for the kind invitation.
After the revision of the manuscript by  the authors and as I already mentioned in our previous
contact, I believe that the manuscript may be published in the recently submitted form.
Please review this paper.
user
Title: Risk of Clostridioides difficile infection in inflammatory bowel disease patients
undergoing vedolizumab treatment: a systematic review and meta-analysis
Version: 4 Date: 19 Sep 2024
Reviewer's report:
Review of the manuscript:
Risk of clostridium difficile infection in inflammatory bowel Disease patients undergoing
vedolizumab treatment: a systematic review and meta-analysis
Thank you again for the kind invitation.
After the revision of the manuscript by  the authors and as I already mentioned in our previous
contact, I believe that the manuscript may be published in the recently submitted form.
assistant